secwatch / observer
8-K filed March 10, 2022, 6:59 PM ET ticker CHRN CIK 0001549084
leadership confidence high sentiment neutral materiality 0.60

Ekso Bionics CCO William Shaw resigns; remains as consultant through June 2022

EKSO BIONICS HOLDINGS, INC.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

William Shaw

Chief Commercial Officer
CHRN · EKSO BIONICS HOLDINGS, INC.
Effective
2022-03-11
Filed
March 10, 2022, 6:59 PM ET
William Shaw, the Chief Commercial Officer of Ekso Bionics Holdings, Inc. (the “Company”) notified the Board of Directors (the “Board”) of his intention to resign as Chief Commercial Officer of the Company effective March 11, 2022

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

William Shaw resigned as Chief Commercial Officer at EKSO BIONICS HOLDINGS, INC..

Action
resigned
Role
Chief Commercial Officer
Exact text from the filing
William Shaw, the Chief Commercial Officer of Ekso Bionics Holdings, Inc. (the “Company”) notified the Board of Directors (the “Board”) of his intention to resign as Chief Commercial Officer of the Company effective March 11, 2022
View on SEC.gov

EKSO BIONICS HOLDINGS, INC. filing history →

Source: SEC EDGAR
accession 0001104659-22-032444
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.